Life science IP covering lab-on-a-chip devices, point-of-care diagnostics, microfluidic biosensors, and sample preparation systems — available for acquisition or exclusive licensing by medical device and diagnostics companies.
Passive capillary force self-propels fluid through microchannels — eliminating the primary cost driver in cartridge-based systems.
Flow can be started, stopped, and directed using only the surface coating — no mechanical components required.
Multiple independent flow rates on a single device layer with no external hardware, power, or electronic control.
Granted Patents
Active US patent portfolio
Patent Citations
Cited by subsequent industry patents
Target Markets
Across life sciences & industrial
Portfolio Extends To
Long runway for licensing partners
Platform Technology
Surface Energy Gradient Coating technology addresses a fundamental engineering challenge — fluid management without mechanical complexity — across a broad range of high-value markets.
Eliminate pumps from cartridge-reader systems. Passive flow reduces hardware cost by 80%+ and enables truly portable field diagnostics.
Pump-free liquid cooling for AI chips, high-density semiconductors, and data center modules — passive, reliable, no moving parts.
Biocompatible passive coatings enable fluid control inside implants without pumps — smaller form factor, longer device life.
Metered passive flow enables controlled drug release without pumps or actuators — transdermal, implantable, and oral applications.
Directional passive fluid management in fuel cells, batteries, and solar panels — no parasitic power draw.
No moving parts. No power requirements. Inherently reliable in high-vibration, vacuum, and zero-gravity environments.
The Technology
A precise gradient in surface energy along microfluidic channel walls generates a net capillary force that self-propels liquid through passages — with no external input of any kind. Multiple flow rates, multiple channels, single device layer.
14+
Compatible Materials
100%
Flow Rate Control
80%+
Hardware Reduction
Zero
Moving Parts
Strategic Fit
This portfolio is directly relevant to any company developing cartridge-based diagnostics, point-of-care devices, or microfluidic sample-handling systems. The companies below represent the primary commercial universe for this technology.
The microfluidics diagnostics market reached $12B+ in 2023 and is growing at nearly 20% annually — with US lab-on-a-chip patents among the most actively licensed IP in life sciences.
Inquire About AcquisitionPrimary Acquisition Targets
Abbott Laboratories
IVD & POC Diagnostics
Thermo Fisher Scientific
Molecular Diagnostics
Becton Dickinson
Diagnostics Systems
Danaher / Cepheid
Rapid Molecular Testing
Bio-Rad Laboratories
Life Science & Clinical
Hologic
Women’s Health Diagnostics
Qiagen
Sample Prep & Assays
Illumina
Genomics & Sequencing
The Team Behind the Technology
Brian Babcock
Inventor & President
Registered US Patent Agent · Vanderbilt B.S./M.S. ChemE · Argonne National Laboratory
Paul Denman
Co-Founder & Business Dev
20+ yrs life sciences, medical device, semiconductor, defense